Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
botulinum toxin Type A
Locations
5
United States
Coral Gables, Florida, United States
South Yarra, Australia
São Paulo, Brazil
Niagara Falls, Ontario, Canada
Cannes, France
Start Date
April 1, 2012
Primary Completion Date
December 31, 2012
Completion Date
December 31, 2012
Last Updated
April 16, 2019
NCT06481475
NCT07321834
NCT06583486
NCT06246552
NCT05089357
NCT06151561
Lead Sponsor
Allergan
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions